Companies: 10,795·Total market cap: $144.5T
Creative Medical Technology Holdings, Inc.

Creative Medical Technology Holdings, Inc.

CELZNASDAQHealthcare● Active
$2.17
+$0.11(+5.31%)
Market Cap$5600028
P/E Ratio
52W High$6.25
52W Low$1.504
Overview

Creative Medical Technology Holdings, Inc. (CELZ) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

CELZ · net income · updated Jun 9, 2026

Core profitability metrics

Net income was −$6.0M for FY2025 (fiscal year ending 2025-12-31), down 9.1% year-over-year. Net profit margin was -99916.8%. Based on available data, Creative Medical Technology Holdings, Inc. has been profitable since at least 2021.

FY2025 Net Income−$6.0M▼ -9.1% YoY
Trailing 12M (TTM)−$5.8Mtrailing 4 quarters sum
Net Profit Margin< −999%−$6.0M ÷ $6,000
YoY Change-9.1%
5-Year CAGRN/AN/A — contains loss years
FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0
Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net IncomeNet LossNet Margin %★ First Profit: 2021

▸ FMP /income-statement · Annual · CELZ net income history · CELZ profit margin

Annual net income data

Fiscal YearNet IncomeYoY ChangeNet Margin
FY2025Loss−$6.0M▼ 9.1%-99916.8%
FY2024Loss−$5.5M▼ 3.9%-49940.7%
FY2023Loss−$5.3M▲ +47.9%-58739.7%
FY2022Loss−$10.1M▼ 152.8%-11449.3%
FY2021★ First Profit$19.2M▲ +152.9%21892.8%

Net income vs peers (Healthcare)

#CompanyNet IncomeYoY
#1
Creative Medical Technology Holdings, Inc.
Creative Medical Technology Holdings, Inc.YOU
CELZ
−$6.0M-9.1%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$26.80B+90.6%
#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$20.64B+94.9%
#4
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$12.06B-16.3%
#5
AbbVie Inc.
AbbVie Inc.
ABBV
$4.23B-1.2%
Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Creative Medical Technology Holdings, Inc. (CELZ) reported net income of −$6.0M for FY2025 (fiscal year ending 2025-12-31), down 9.1% year-over-year. The net profit margin was -99916.8% — meaning the company kept $-999.17 of every dollar of revenue as profit.

Based on available data, Creative Medical Technology Holdings, Inc. has been profitable since at least 2021. Net income reached a peak of $19.2M in FY2021. Data available for 15 fiscal years.

Creative Medical Technology Holdings, Inc.'s net profit margin was -99916.8% for FY2025, based on the latest annual results.

Investors sometimes search for "Creative Medical Technology Holdings, Inc. net worth" — the company's market capitalization is a separate figure from CELZ net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Frequently asked questions

CELZ net income · 4 questions

Creative Medical Technology Holdings, Inc. is not currently profitable on an annual basis. The company reported a net loss of $6.0M for FY2025.

is CELZ profitabledoes CELZ make a profitCELZ profitabilityCELZ profitable company

Source: FMP /income-statement · GAAP · Creative Medical Technology Holdings, Inc. · Creative Medical Technology Holdings, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026